Atelectasis Formation: Role of Positive Pressure Breathing, Hyperoxia, and Hypobaria
NCT ID: NCT03311347
Last Updated: 2019-05-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2015-09-14
2020-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A secondary aim is to evaluate the effect of anti G-trouser inflation on ventilation and regional perfusion.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Hyperoxia and Hypergravity on Lung Ventilation and Perfusion
NCT01993394
Pressure Support and Positive End Expiratory Pressure During Spontaneous Breathing Trial
NCT03861117
Comparison of Positive End Expiratory Pressure Titration Methods in ARDS Patients
NCT03281473
Global Physiotherapy in ICU Patients With High Risk Extubation Failure
NCT05423301
EXtubation With SUctioning or With Positive End-Expiratory Pressure in Intensive Care Unit
NCT05147636
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study is conducted in accordance with the amended Declaration of Helsinki. The Ethics Committee Ile-de-France III (ref. 3274) and the French National Agency for Drug Safety ANSM have approved the protocol (ref. ID RCB 2015-A00485-44 and ANSM 151046B-32).
Primary aim, item 1: Experiments are conducted in a human centrifuge. The protocol mimics a routine peacetime flight in combat aircraft, and includes 1hr05 min at +1Gz followed by 10-min exposure to +1.4 to +3.5Gz . Subjects are exposed three times to this sequence, breathing at positive pressure levels of 0, 5 or 10 hPa. Two groups of sixteen healthy male non-smoking volunteers, wearing anti-G trousers, are studied and compared: group 1 breathes air, group 2 100% O2.
Primary aim, item 2: Experiments are conducted in a hypobaric chamber. Sixteen healthy male non-smoking volunteers are exposed to four conditions: 0 or 15,000 ft altitude, breathing air or 100%O2. Protocol duration is 1h15min. Positive breathing pressure can be applied depending on the results of the experiments of item 1.
Secondary aim: Experiments are conducted in a human centrifuge. Sixteen healthy male non-smoking volunteers are exposed to four conditions: uninflated or inflated anti-G trousers (175 hPa), +1 or +3.5 Gz for 3 min.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
100%O2 breathing
Primary aim, item 1
+Gz accelerations and positive pressure breathing
Air breathing
Primary aim, item 1
+Gz accelerations and positive pressure breathing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
+Gz accelerations and positive pressure breathing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* normal ECG
* normal clinical examination
Exclusion Criteria
* myopia
* past medical history of heart or lung disease
* current medical treatment for heart or lung disease
* past medical history of back pain or spine trauma or disease
* otitis
* bad tolerance to +Gz accelerations (G-induced loss of consciousness, motion sickness)
* claustrophobia in the centrifuge gondola
* smoking
* past medical history of heart or lung disease
* current medical treatment for heart or lung disease
* otitis
* bad tolerance to the altitude chamber (15,000 ft): ear pain, claustrophobia
25 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uppsala University Hospital
OTHER
Percy Hospital
UNKNOWN
Direction Centrale du Service de Santé des Armées
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dominique Felten, MD
Role: STUDY_CHAIR
Armed Forces Biomedical Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Armed Forces Biomedical Research Institute
Brétigny-sur-Orge, , France
Department of Radiology, Percy hospital
Clamart, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Dussault C, Gontier E, Verret C, Soret M, Boussuges A, Hedenstierna G, Montmerle-Borgdorff S. Hyperoxia and hypergravity are independent risk factors of atelectasis in healthy sitting humans: a pulmonary ultrasound and SPECT/CT study. J Appl Physiol (1985). 2016 Jul 1;121(1):66-77. doi: 10.1152/japplphysiol.00085.2016. Epub 2016 Apr 21.
Borges JB, Hedenstierna G, Bergman JS, Amato MB, Avenel J, Montmerle-Borgdorff S. First-time imaging of effects of inspired oxygen concentration on regional lung volumes and breathing pattern during hypergravity. Eur J Appl Physiol. 2015 Feb;115(2):353-63. doi: 10.1007/s00421-014-3020-9. Epub 2014 Oct 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PDH1-SMO2-0714
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.